Cigna Group 10-Q

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS Issuer Purchases of Equity Securities The following table provides information about The Cigna Group share repurchase activity for the quarter ended June 30, 2026: Period Total # of shares purchased (1) Average price paid per share (1) (3) Total # of shares purchased as part of publicly announced program (2) Approximate dollar value of shares that may yet be purchased as part of publicly announced program (3) (in millions) April 1 - 30, 2026 663 $ 268.55 — $ 6,730 May 1 - 31, 2026 864,782 $ 289.18 864,544 $ 6,480 June 1 - 30, 2026 10,003 $ 286.56 — $ 6,480 Total 875,448 $ 289.13 864,544 N/A (1) Includes shares tendered by employees under the Company's equity compensation plans as follows: 1) payment of taxes on vesting of restricted stock (grants and units) and strategic performance shares and 2) payment of the exercise price and taxes for certain stock options exercised. Employees tendered 663 shares in April, 238 shares in May and 10,003 shares in June 2026. (2) Additionally, the Company maintains a share repurchase program authorized by the Board. Under this program, the Company may repurchase shares from time to time, depending on market conditions and alternate uses of capital. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. The share repurchase program may be effected through Rule 10b5-1 plans, open market purchases, each in compliance with Rule 10b-18 under the Exchange Act, or privately negotiated transactions. The program may be suspended or discontinued at any time and does not have an expiration date. (3) The average price paid per share and approximate dollar value of shares exclude the impact of excise tax.